baclofen has been researched along with nifedipine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.00) | 18.7374 |
| 1990's | 11 (44.00) | 18.2507 |
| 2000's | 9 (36.00) | 29.6817 |
| 2010's | 3 (12.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Catt, KJ; Stojilković, SS; Virmani, MA | 1 |
| Al-Dahan, MI; Thalmann, RH | 1 |
| Acs, Z; Horváth, G; Makara, GB; Mergl, Z; Nagy, I | 1 |
| Eriksson, PS; Hansson, E; Nilsson, M; Rönnbäck, L | 1 |
| Haugh-Scheidt, L; Malchow, RP; Ripps, H | 1 |
| Gean, PW; Huang, CC; Wang, SJ | 1 |
| Heick, A | 1 |
| Hounsgaard, J; Svirskis, G | 1 |
| Borst, JG; Sakmann, B; Wu, LG | 1 |
| Moises, HC; Rusin, KI | 1 |
| Forsythe, ID; Harasztosi, C; Rusznák, Z; Stanfield, PR; Szûcs, G | 1 |
| Bence, M; Everest, H; Forrest-Owen, W; Lightman, SL; McArdle, CA; Williams, B | 1 |
| Easter, A; Spruce, AE | 2 |
| Altobelli, D; Fuxe, K; Martire, M; Maurizi, S; Preziosi, P | 1 |
| Nagy, F; Voisin, DL | 1 |
| Carrasquillo, JA; Chen, CC; Dunleavy, K; Nguyen, JD | 1 |
1 review(s) available for baclofen and nifedipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
24 other study(ies) available for baclofen and nifedipine
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Intractable hiccup: baclofen and nifedipine are worth trying.
Topics: Baclofen; Hiccup; Humans; Nifedipine | 1990 |
Stimulation of luteinizing hormone release by gamma-aminobutyric acid (GABA) agonists: mediation by GABAA-type receptors and activation of chloride and voltage-sensitive calcium channels.
Topics: Amino Acid Sequence; Animals; Baclofen; Calcium Channels; Cells, Cultured; Chloride Channels; Chlorides; Female; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Isoxazoles; Luteinizing Hormone; Membrane Proteins; Molecular Sequence Data; Muscimol; Nifedipine; Pituitary Gland, Anterior; Pyridazines; Rats; Rats, Inbred Strains; Receptors, GABA-A | 1990 |
Effects of dihydropyridine calcium channel ligands on rat brain gamma-aminobutyric acidB receptors.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Baclofen; Binding, Competitive; Calcium Channels; Dihydropyridines; Male; Nifedipine; Rats; Receptors, GABA-A | 1989 |
gamma-Aminobutyric acid-induced elevation of intracellular calcium concentration in pituitary cells of neonatal rats.
Topics: Animals; Animals, Newborn; Baclofen; Calcium; Female; Fura-2; gamma-Aminobutyric Acid; In Vitro Techniques; Muscimol; Nifedipine; Picrotoxin; Pituitary Gland; Potassium Chloride; Rats; Rats, Wistar; Receptors, GABA-A; Verapamil | 1993 |
GABA induces Ca2+ transients in astrocytes.
Topics: Animals; Astrocytes; Baclofen; Bicuculline; Calcium; Cells, Cultured; Cerebral Cortex; Cytosol; gamma-Aminobutyric Acid; Immunohistochemistry; Muscimol; Nicotinic Acids; Nifedipine; Rats | 1993 |
GABA transport and calcium dynamics in horizontal cells from the skate retina.
Topics: Animals; Baclofen; Bicuculline; Biological Transport; Calcium; Calcium Channel Blockers; Dantrolene; Electrophysiology; GABA Antagonists; gamma-Aminobutyric Acid; Membrane Potentials; Muscle Relaxants, Central; Nifedipine; Picrotoxin; Retina; Skates, Fish | 1995 |
Investigations on the mechanism of tetrahydro-9-aminoacridine-induced presynaptic inhibition in the rat amygdala.
Topics: 4-Aminopyridine; Alzheimer Disease; Amygdala; Animals; Baclofen; Dose-Response Relationship, Drug; Male; Membrane Potentials; Nifedipine; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Tacrine; Time Factors | 1996 |
[Diabolic hiccup].
Topics: Baclofen; Brain Stem; Calcium Channel Blockers; Chlorpromazine; Dopamine Antagonists; GABA Agents; Hiccup; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nifedipine; Time Factors; Valproic Acid | 1997 |
Transmitter regulation of plateau properties in turtle motoneurons.
Topics: Animals; Atropine; Baclofen; Benzoates; Calcium Channels; Calcium Channels, L-Type; Cycloleucine; Excitatory Amino Acid Antagonists; Glycine; In Vitro Techniques; Membrane Potentials; Motor Neurons; Muscarine; Nifedipine; Patch-Clamp Techniques; Receptors, Metabotropic Glutamate; Resorcinols; Spinal Cord; Tetraethylammonium; Tetrodotoxin; Turtles | 1998 |
R-type Ca2+ currents evoke transmitter release at a rat central synapse.
Topics: Action Potentials; Animals; Baclofen; Brain Stem; Cadmium Chloride; Calcium Channel Blockers; Calcium Channels; Electric Stimulation; Evoked Potentials; In Vitro Techniques; Neurons; Nickel; Nifedipine; Nimodipine; omega-Agatoxin IVA; omega-Conotoxins; Patch-Clamp Techniques; Peptides; Rats; Rats, Wistar; Receptors, GABA-B; Receptors, Metabotropic Glutamate; Spider Venoms; Synapses | 1998 |
Mu-opioid and GABA(B) receptors modulate different types of Ca2+ currents in rat nodose ganglion neurons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analgesics, Opioid; Animals; Baclofen; Cadmium; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Channels, N-Type; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; GABA Agonists; GABA Antagonists; Naloxone; Narcotic Antagonists; Nerve Tissue Proteins; Neurons; Nifedipine; Nodose Ganglion; omega-Agatoxin IVA; omega-Conotoxin GVIA; omega-Conotoxins; Patch-Clamp Techniques; Peptides; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Receptors, Opioid, mu; Spider Venoms | 1998 |
Possible modulatory role of voltage-activated Ca(2+) currents determining the membrane properties of isolated pyramidal neurones of the rat dorsal cochlear nucleus.
Topics: Animals; Antibody Specificity; Baclofen; Calcium Channel Blockers; Calcium Channels; Cochlear Nucleus; Cycloleucine; GABA Agonists; Immunochemistry; In Vitro Techniques; Membrane Potentials; Nifedipine; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate | 1999 |
GABAA receptor mediated elevation of Ca2+ and modulation of gonadotrophin-releasing hormone action in alphaT3-1 gonadotropes.
Topics: Anesthetics; Animals; Baclofen; Bicuculline; Biological Transport; Calcium; Calcium Channel Blockers; Cells, Cultured; Chlorides; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Mice; Muscimol; Nifedipine; Picrotoxin; Pituitary Gland; Pregnanediones; Receptors, GABA-A; Receptors, GABA-B | 2000 |
Modulation of calcium current by recombinant GABA(B) receptors.
Topics: Animals; Baclofen; Calcium Channel Blockers; Calcium Channels; GABA Agonists; Glioma; Hybrid Cells; Membrane Potentials; Neuroblastoma; Nifedipine; Nimodipine; Norepinephrine; Protein Subunits; Receptors, GABA-B; Recombinant Proteins; Transfection | 2000 |
K(+)-Evoked [(3)H]D-aspartate release in rat spinal cord synaptosomes: modulation by neuropeptide Y and calcium channel antagonists.
Topics: Animals; Aspartic Acid; Baclofen; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Ion Channel Gating; Male; Nerve Endings; Neuropeptide Y; Nifedipine; omega-Conotoxin GVIA; Peptide Fragments; Potassium; Protein Isoforms; Rats; Rats, Wistar; Spinal Cord; Stereoisomerism; Synaptosomes | 2000 |
Sustained L-type calcium currents in dissociated deep dorsal horn neurons of the rat: characteristics and modulation.
Topics: Animals; Baclofen; Barium; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cycloleucine; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; GABA Agonists; Glycine; In Vitro Techniques; Male; Membrane Potentials; Nifedipine; Patch-Clamp Techniques; Posterior Horn Cells; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Resorcinols | 2001 |
Recombinant GABA(B) receptors formed from GABA(B1) and GABA(B2) subunits selectively inhibit N-type Ca(2+) channels in NG108-15 cells.
Topics: Animals; Baclofen; Calcium Channels, T-Type; DNA, Antisense; DNA, Recombinant; GABA Agonists; GABA Antagonists; Membrane Potentials; Nifedipine; Norepinephrine; omega-Conotoxin GVIA; Phosphinic Acids; Plasmids; Propanolamines; Protein Subunits; Receptors, GABA-B; Transfection; Tumor Cells, Cultured | 2002 |
F-18 fluorodeoxyglucose positron emission tomographic imaging in a patient with persistent hiccups.
Topics: Baclofen; Brain; Brain Neoplasms; Chlorpromazine; Diagnosis, Differential; Fluorodeoxyglucose F18; Hiccup; Humans; Magnetic Resonance Imaging; Male; Multiple Myeloma; Muscle Relaxants, Central; Nifedipine; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Failure | 2004 |